New Mexico · 87635

Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen in New Mexico

New Mexico Medicare Avg
$48.92
2% below national avg
National Medicare Avg
$50.08
All states combined
Billed Charge (NM)
$114.42
What providers submit
Est. Commercial (NM)
$105.22
National avg: $112.17
Est. Cash / Self-Pay (NM)
$68.17
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

2.5K
Services in NM
198
Providers
N/A
Min Payment
N/A
Max Payment

New Mexico Pricing in Context

In New Mexico, CPT code 87635 (Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen) carries an average Medicare payment of $48.92 — 2% below the national benchmark of $50.08. 198 providers across the state submitted claims for this procedure in 2023, performing 2.5K total services. Individual payments in NM ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New Mexico is $114.42, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Mexico sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in New Mexico lands near $105.22, with self-pay cash prices typically around $68.17. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen cost in New Mexico?

The average Medicare payment for Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen in New Mexico is $48.92, which is 2% below the national average of $50.08. Providers in NM typically bill $114.42 for this procedure.

What does Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen cost with insurance in New Mexico?

With commercial insurance in New Mexico, Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen costs an estimated $105.22. Without insurance, the estimated cash price is $68.17. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen in New Mexico?

198 providers in New Mexico billed Medicare for Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen in 2023, performing 2.5K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen cheaper in New Mexico than the national average?

Yes — Amplifed Dna Or Rna Probe Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antigen costs 2% below the national average in New Mexico. The state average Medicare payment is $48.92 compared to $50.08 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial